BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates
read more...
Nov 06, 2024
BeiGene to Present at the Jefferies London Healthcare Conference
| RegularNews read more...
Nov 06, 2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
| Monthly Returns read more...
Nov 05, 2024
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
read more...
Nov 05, 2024
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
| Announcements and Notices read more...
Nov 01, 2024
Next Day Disclosure Return
| Next Day Disclosure Returns read more...
Oct 30, 2024
Next Day Disclosure Return
| Next Day Disclosure Returns read more...
Oct 29, 2024
Next Day Disclosure Return
| Next Day Disclosure Returns read more...
Oct 29, 2024
DATE OF AUDIT COMMITTEE MEETING
| Announcements and Notices read more...
Oct 28, 2024
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
| Announcements and Notices read more...
Oct 28, 2024
PASSING AWAY OF AN INDEPENDENT
NON-EXECUTIVE DIRECTOR
| Announcements and Notices read more...
Oct 28, 2024
BeiGene Mourns Death of Beloved Board Member Donald Glazer
| RegularNews read more...
Oct 23, 2024
BeiGene Named Manufacturer of the Year by the National Association of Specialty Pharmacy (NASP)
read more...
Oct 21, 2024
BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma
| RegularNews read more...
